Unity Biotechnology (UBX)

• Market cap: $16.9M
• 1 day: -5.66%
• 5 days: -14.53%
• 1 month: -35.48%
• 3 months: -21.88%
• 6 months: -30.56%
• Year to date: -12.28%
• 1 year: -36.71%
• 5 years: -98.19%
• 10 years: -99.40%
• Sector: Healthcare
• Industry: Biotechnology

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

1.68% less ownership

Funds ownership: 20.54% [Q3] → 18.86% (-1.68%) [Q4]

3% less funds holding

Funds holding: 38 [Q3] → 37 (-1) [Q4]

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

39% less capital invested

Capital invested by funds: $5.09M [Q3] → $3.11M (-$1.98M) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $4 300% upside
• Avg. target: $4 300% upside
• High target: $4 300% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Chardan Capital Daniil Gataulin 24% 1-year accuracy 4 / 17 met price target	300% upside $4	Buy Maintained	25 Mar 2025
HC Wainwright & Co. Matthew Caufield 31% 1-year accuracy 20 / 64 met price target	300% upside $4	Buy Maintained	25 Mar 2025